NCT02130258

Brief Summary

The investigators hypothesize that there may exist different quantitative sensory profiles between radicular pain patients who respond and those who do not respond to the standard therapy of epidural steroid injections (ESI).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2012

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

April 24, 2014

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 5, 2014

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
2 months until next milestone

Results Posted

Study results publicly available

February 8, 2018

Completed
Last Updated

February 8, 2018

Status Verified

February 1, 2018

Enrollment Period

4.6 years

First QC Date

April 24, 2014

Results QC Date

November 30, 2017

Last Update Submit

February 7, 2018

Conditions

Keywords

RadicularPainEpidural Steroid Injection

Outcome Measures

Primary Outcomes (3)

  • Pre-epidural Warm Sensation Quantitative Sensory Testing (QST) Results

    QST tests for changes in spinal nerves. A small metal plate, called a thermode, is placed on the subject's arm. During the warm sensation test, the plate slowly increases in temperature.The subject will stop the test as soon as the plate feels warm. This temperature is recorded and can range from 32-53 degrees Celsius. The same test is repeated on the subject's leg that has radicular pain. The difference in temperatures from the test on the subject's arm and leg were analyzed.

    Baseline measurement before the epidural injection

  • Post-epidural Continued Pain Modulation (CPM)

    CPM is a type of QST where the thermode is placed on the subject's non painful arm. Heat stimulation (47 degrees C, 4 seconds) was delivered to the thermode 4 times and the subject rated the pain felt by the heat stimulation on a visual analog scale (VAS) of 0-10. During the second heat stimulation, the subject immersed their hand (opposite from the arm with the thermode) in 12 degree C water and then rated the pain felt by the heat on a VAS of 0-10 (10 is the worst pain a subject can imagine, 0 is no pain). The final 2 heat stimuli were delivered (without using the hand submerged in water). This same test was repeated with the thermode on the subject's leg with radicular pain. The subject placed their hand contralateral to the painful leg in the cold water during the second heat stimulation. The VAS scores from each heat stimulation were averaged for the non-painful arm and the painful leg. The difference in averages between the arm and leg were then analyzed.

    4 weeks after the epidural injection

  • Post-epidural Cold Pain Threshold QST Results

    The thermode is placed on the subject's arm. During the cold pain threshold test, the plate slowly decreases in temperature.The subject will stop the test when the plate is at their minimal tolerable temperature. This temperature is recorded and can range from 32-0 degrees Celsius. The same test is repeated on the subject's leg that has radicular pain. The difference in temperatures from the test on the subject's arm and leg were analyzed.

    4 weeks after the epidural injection

Study Arms (2)

>30% Pain Relief

OTHER

All subjects have radicular pain and are scheduled to receive an epidural steroid injection (ESI) as a treatment. The ESI treatment is conducted by the subject's clinical physician and is not given as part of the research study procedures. Quantitative Sensory Testing (QST) will be conducted before and after the ESI treatment. QST consists of hot and cold temperature testing using the QST device. This group of subjects received greater than 30% pain relief.

Device: Quantitative Sensory Testing (QST)Procedure: Epidural Steroid Injection (ESI)

<30% Pain Relief

OTHER

All subjects have radicular pain and are scheduled to receive an epidural steroid injection (ESI) as a treatment. The ESI treatment is conducted by the subject's clinical physician and is not given as part of the research study procedures. Quantitative Sensory Testing (QST) will be conducted before and after the ESI treatment. QST consists of hot and cold temperature testing using the QST device. This group of subjects received less than 30% pain relief.

Device: Quantitative Sensory Testing (QST)Procedure: Epidural Steroid Injection (ESI)

Interventions

Subjects will undergo hot and cold temperature testing using the QST device at two points: 1) Before ESI and 2) after ESI.

<30% Pain Relief>30% Pain Relief

Subjects will receive an ESI by their clinical physician as part of their clinical treatment. This procedure is not given as part of the research study.

<30% Pain Relief>30% Pain Relief

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of lower extremity radicular pain regardless of specific or suspected etiologies
  • scheduling an epidural steroid injection (ESI)

You may not qualify if:

  • a major psychiatric disorder requiring a recent (within one month) hospitalization, such as major depression, bipolar disorder, schizophrenia, anxiety disorder, and psychosis
  • subject is taking illicit or recreational drug detected through a urine toxicology screen
  • subject has had an interventional pain management procedures within the last eight weeks that may alter QST responses including neuraxial or local anesthetic block
  • subject had a change in dosage of neuromodulatory pain medication (including gabapentin, pregabalin, cymbalta, amitriptyline, nortriptyline, trileptal, etc) in the past two weeks
  • subject is pregnant
  • subject has pending litigation involving the current pain condition being treated and studied.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MGH Center for Translational Pain Research

Boston, Massachusetts, 02114, United States

Location

Related Links

MeSH Terms

Conditions

RadiculopathyPain

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Yi Zhang
Organization
Massachusetts General Hospital

Study Officials

  • Yi Zhang, MD, PhD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 24, 2014

First Posted

May 5, 2014

Study Start

May 1, 2012

Primary Completion

December 1, 2016

Study Completion

December 1, 2017

Last Updated

February 8, 2018

Results First Posted

February 8, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

Locations